BDBM436987 2-[6-(5-Chloro-4-methyl-2-thienyl)-3-methyl-2-oxo-imidazo[4,5-b]pyridin-1- yl]-N,N-dimethyl-acetamide::US10617676, Example 322::US11207298, Example 322

SMILES CN(C)C(=O)Cn1c2cc(cnc2n(C)c1=O)-c1cc(C)c(Cl)s1

InChI Key InChIKey=GCHXTEIDUFZVEP-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 436987   

TargetGlutamate receptor ionotropic, NMDA 1/2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM436987(US10617676, Example 322 | 2-[6-(5-Chloro-4-methyl-...)
Affinity DataIC50: 23nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/2/2022
Entry Details
US Patent

TargetGlutamate receptor ionotropic, NMDA 2B(Human)
Janssen Pharmaceutica

US Patent
LigandPNGBDBM436987(US10617676, Example 322 | 2-[6-(5-Chloro-4-methyl-...)
Affinity DataIC50: 23nMAssay Description:NMDA receptors are ion channels that are highly permeable to Ca2+ ions, rendering it possible to monitor NMDA receptor function using cell-based calc...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/13/2020
Entry Details
US Patent